Essential Hypertension
Showing NaN - NaN of 8
Essential Hypertension Trial in Korea, Republic of (CS8635 20/5/12.5mg and , Olmetec® Plus 20/12.5mg and )
Completed
- Essential Hypertension
- CS8635 20/5/12.5mg and placebo
- Olmetec® Plus 20/12.5mg and placebo
-
Ansan, Korea, Republic of
- +38 more
Dec 20, 2018
Essential Hypertension Trial in Worldwide (LCZ696, Amlodipine, Placebo)
Essential Hypertension Trial in Worldwide (Olmesartan, Placebo, LCZ696)
Completed
- Essential Hypertension
- Olmesartan
- +2 more
-
Chongqing, Chongqing, China
- +77 more
Oct 1, 2015
Essential Hypertension Trial in Worldwide (LCZ696, Amlodipine, Hydrochlorothiazide (HCTZ))
Essential Hypertension Trial in Korea, Republic of (Amlodipine 5mg, Amlodipine 5mg, Candesartan cilexetil 16mg, Amlodipine 10mg,
Unknown status
- Essential Hypertension
- Amlodipine 5mg
- +2 more
-
Anyang-si, Korea, Republic of
- +18 more
Feb 16, 2015
Essential Hypertension Trial in Korea, Republic of (Candesartan cilexetil 16mg, Amlodipine 10mg, Candesartan cilexetil 16mg)
Unknown status
- Essential Hypertension
- Candesartan cilexetil 16mg
- Amlodipine 10mg, Candesartan cilexetil 16mg
-
Anyang-si, Korea, Republic of
- +18 more
Feb 16, 2015
Essential Hypertension Trial in Korea, Republic of (Amlodipine 5mg, Amlodipine 10mg, Candesartan Cilexetil 8mg)
Unknown status
- Essential Hypertension
- Amlodipine 5mg
- +3 more
-
Bundang, Korea, Republic of
- +19 more
Apr 29, 2014
Essential Hypertension, Chronic Stable Angina, CHF Trial in Daegu (Dilatrend SR capsule 32mg, Dilatrend IR tablet 25mg)
Unknown status
- Essential Hypertension
- +2 more
- Dilatrend SR capsule 32mg
- Dilatrend IR tablet 25mg
-
Daegu, eok-dong 2(i)-ga Jung-gu, Korea, Republic ofKyungpook National University Hospital Clinical Trial Center
Mar 29, 2013